JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1991; 17:758-769
© 1991 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Forrester, J.
Right arrow Articles by Fagin, J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Forrester, J.
Right arrow Articles by Fagin, J

A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies

JS Forrester, M Fishbein, R Helfant, and J Fagin

Division of Cardiology, Cedars-Sinai Medical Center, Los Angeles, California 90048.

Angioplasty causes substantial injury to the coronary artery intima and media that is unrecognizable by angiography. On the basis of a substantial body of research in oncology and wound healing, it is hypothesized that restenosis is a manifestation of the general wound healing response expressed specifically in vascular tissue. The temporal response to injury occurs in three characteristic phases: inflammation, granulation and extracellular matrix remodeling. The specific expression of these phases in the coronary artery leads to intimal hyperplasia at 1 to 4 months. The major milestones in the temporal sequence of restenosis are platelet aggregation, inflammatory cell infiltration, release of growth factors, medial smooth muscle cell modulation and proliferation, proteoglycan deposition and extracellular matrix remodeling. Each step has potential inhibitors that could be used for preventive therapy. Resolution of restenosis, however, probably requires both creation of the largest possible residual lumen and substantial inhibition of intimal hyperplasia.


This article has been cited by other articles:


Home page
ANGIOLOGYHome page
C. Schindler, A. Mueller, P. Bramlage, W. Boecking, W. Kirch, and J. Schweizer
Comparison of Selective AT1-Receptor Blockade Versus ACE Inhibition for Restenosis Prophylaxis in Patients With Peripheral Occlusive Arterial Disease After Stent Angioplasty: A Randomized, Controlled, Proof-of-Concept Study
Angiology, January 1, 2008; 58(6): 710 - 716.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
E. Karshovska, A. Zernecke, G. Sevilmis, A. Millet, M. Hristov, C. D. Cohen, H. Schmid, F. Krotz, H.-Y. Sohn, V. Klauss, et al.
Expression of HIF-1{alpha} in Injured Arteries Controls SDF-1{alpha} Mediated Neointima Formation in Apolipoprotein E Deficient Mice
Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2540 - 2547.
[Abstract] [Full Text] [PDF]


Home page
VASC ENDOVASCULAR SURGHome page
J. A. Reid, L. L. Lau, R. J. Hannon, B. Lee, I. S. Young, and C. V. Soong
Decreased Antioxidant Vitamin Concentration May Be a Risk Factor for Recurrent Carotid Stenosis
Vascular and Endovascular Surgery, September 1, 2007; 41(4): 330 - 334.
[Abstract] [PDF]


Home page
Clin TrialsHome page
C. E. Lok, M. Allon, S. Donnelly, M. Dorval, B. Hemmelgarn, L. Moist, M. J. Oliver, M. Tonelli, and K. Stanley
Design of the fish oil inhibition of stenosis in hemodialysis grafts (FISH) study
Clinical Trials, August 1, 2007; 4(4): 357 - 367.
[Abstract] [PDF]


Home page
FASEB J.Home page
L. S. M. Boesten, A. S. M. Zadelaar, A. van Nieuwkoop, L. Hu, J. Jonkers, B. van de Water, M. J. J. Gijbels, I. van der Made, M. P. J. de Winther, L. M. Havekes, et al.
Macrophage retinoblastoma deficiency leads to enhanced atherosclerosis development in ApoE-deficient mice
FASEB J, May 1, 2006; 20(7): 953 - 955.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. C. Morton, N. D. Arnold, J. Gunn, R. Varcoe, S. E. Francis, S. K. Dower, and D. C. Crossman
Interleukin-1 receptor antagonist alters the response to vessel wall injury in a porcine coronary artery model
Cardiovasc Res, December 1, 2005; 68(3): 493 - 501.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Wang, X. Zhou, Z. Zhou, N. Mal, L. Fan, M. Zhang, A. M. Lincoff, E. F. Plow, E. J. Topol, and M. S. Penn
Platelet, Not Endothelial, P-Selectin Is Required for Neointimal Formation After Vascular Injury
Arterioscler. Thromb. Vasc. Biol., August 1, 2005; 25(8): 1584 - 1589.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. A. Costa and D. I. Simon
Molecular Basis of Restenosis and Drug-Eluting Stents
Circulation, May 3, 2005; 111(17): 2257 - 2273.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Takahashi and R. T. Lee
Dendritic cells in neointima formation: from where did you come, and what are you doing here?
J. Am. Coll. Cardiol., September 3, 2003; 42(5): 939 - 941.
[Full Text] [PDF]


Home page
RadiologyHome page
M. Schillinger, M. Exner, W. Mlekusch, M. Haumer, H. Rumpold, R. Ahmadi, S. Sabeti, O. Wagner, and E. Minar
Endovascular Revascularization Below the Knee: 6-month Results and Predictive Value of C-reactive Protein Level
Radiology, May 1, 2003; 227(2): 419 - 425.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
M. Schillinger, M. Exner, W. Mlekusch, H. Rumpold, R. Ahmadi, S. Sabeti, W. Lang, O. Wagner, and E. Minar
Acute-Phase Response after Stent Implantation in the Carotid Artery: Association with 6-month In-Stent Restenosis
Radiology, May 1, 2003; 227(2): 516 - 521.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
R Virmani, F D Kolodgie, A Farb, and A Lafont
Drug eluting stents: are human and animal studies comparable?
Heart, February 1, 2003; 89(2): 133 - 138.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
F. Versaci, A. Gaspardone, F. Tomai, F. Ribichini, P. Russo, I. Proietti, A. S. Ghini, V. Ferrero, L. Chiariello, P. Agostino Gioffre, et al.
Immunosuppressive therapy for the prevention of restenosis after coronary artery stent implantation (IMPRESS study)
J. Am. Coll. Cardiol., December 4, 2002; 40(11): 1935 - 1942.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. G.P. Welt and C. Rogers
Inflammation and Restenosis in the Stent Era
Arterioscler. Thromb. Vasc. Biol., November 1, 2002; 22(11): 1769 - 1776.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
M. Schillinger, M. Exner, W. Mlekusch, H. Rumpold, R. Ahmadi, S. Sabeti, M. Haumer, O. Wagner, and E. Minar
Vascular Inflammation and Percutaneous Transluminal Angioplasty of the Femoropopliteal Artery: Association with Restenosis
Radiology, October 1, 2002; 225(1): 21 - 26.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
H. Alfke, J. J. Froelich, S. Nowak, and H.-J. Wagner
Cardiovascular Risk Factors Do Not Predict Clinically Defined Restenosis After Percutaneous Transluminal Angioplasty for Lower Limb Ischemia
Angiology, January 1, 2002; 53(1): 15 - 20.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
K. Kanamasa, Y. Inoue, N. Otani, N. Naito, H. Morii, A. Ikeda, M. Taniguchi, N. Ishida, T. Hayashi, and K. Ishikawa
tPA via Infusion Catheters Followed by Continuous IV Infusion for 3 Days Prevents Intimal Hyperplasia After Balloon Injury
Angiology, December 1, 2001; 52(12): 819 - 825.
[Abstract] [PDF]


Home page
Br Med BullHome page
E Regar, G Sianos, and P W Serruys
Stent development and local drug delivery
Br. Med. Bull., October 1, 2001; 59(1): 227 - 248.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. Wang, Z. Zhou, X. Zhou, K. Tarakji, E. J. Topol, and A. M. Lincoff
Prevention of intimal hyperplasia with recombinant soluble P-selectin glycoprotein ligand-immunoglobulin in the porcine coronary artery balloon injury model
J. Am. Coll. Cardiol., August 1, 2001; 38(2): 577 - 582.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
M. Kalinowski, H. Alfke, S. Bergen, K. J. Klose, J. J. Barry, and H.-J. Wagner
Comparative Trial of Local Pharmacotherapy with L-Arginine, r-Hirudin, and Molsidomine to Reduce Restenosis after Balloon Angioplasty of Stenotic Rabbit Iliac Arteries
Radiology, June 1, 2001; 219(3): 716 - 723.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
K. Aragane, K. Fujinami, K. Kojima, and J. Kusunoki
ACAT inhibitor F-1394 prevents intimal hyperplasia induced by balloon injury in rabbits
J. Lipid Res., April 1, 2001; 42(4): 480 - 488.
[Abstract] [Full Text]


Home page
CirculationHome page
R. S. Kiesz, P. Buszman, J. L. Martin, E. Deutsch, M. M. Rozek, E. Gaszewska, M. Rewicki, P. Seweryniak, M. Kosmider, and M. Tendera
Local Delivery of Enoxaparin to Decrease Restenosis After Stenting: Results of Initial Multicenter Trial : Polish-American Local Lovenox NIR Assessment Study (The POLONIA Study)
Circulation, January 2, 2001; 103(1): 26 - 31.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
B. Zhu, D. G. Kuhel, D. P. Witte, and D. Y. Hui
Apolipoprotein E Inhibits Neointimal Hyperplasia after Arterial Injury in Mice
Am. J. Pathol., December 1, 2000; 157(6): 1839 - 1848.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Uemura, C. G. Fathman, J. B. Rothbard, and J. P. Cooke
Rapid and Efficient Vascular Transport of Arginine Polymers Inhibits Myointimal Hyperplasia
Circulation, November 21, 2000; 102(21): 2629 - 2635.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Chajara, M. Raoudi, B. Delpech, M. Leroy, J. P. Basuyau, and H. Levesque
Increased Hyaluronan and Hyaluronidase Production and Hyaluronan Degradation in Injured Aorta of Insulin-Resistant Rats
Arterioscler. Thromb. Vasc. Biol., June 1, 2000; 20(6): 1480 - 1487.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. B. King III
Acute myocardial infarction: are diabetics different?
J. Am. Coll. Cardiol., May 1, 2000; 35(6): 1513 - 1515.
[Full Text] [PDF]


Home page
ANGIOLOGYHome page
I. Ogawa, T. Hayashi, T. Nakabayashi, N. Otani, K. Ishikawa, and K. Kanamasa
Prevention of Coronary Arterial Renarrowing by Continuous 3-Day Infusion of Tissue Plasminogen Activator After Successful Percutaneous Transluminal Coronary Angioplasty: A Randomized, Double-Blind, Placebo-Controlled Study
Angiology, May 1, 2000; 51(5): 367 - 375.
[Abstract] [PDF]


Home page
CirculationHome page
P. W. Serruys, D. P. Foley, B. Hofling, J. Puel, H. D. Glogar, R. Seabra-Gomes, J. Goicolea, P. Coste, W. Rutsch, H. Katus, et al.
Carvedilol for Prevention of Restenosis After Directional Coronary Atherectomy : Final Results of the European Carvedilol Atherectomy Restenosis (EUROCARE) Trial
Circulation, April 4, 2000; 101(13): 1512 - 1518.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K.-Y. Chyu, P. Dimayuga, J. Zhu, J. Nilsson, S. Kaul, P. K. Shah, and B. Cercek
Decreased Neointimal Thickening After Arterial Wall Injury in Inducible Nitric Oxide Synthase Knockout Mice
Circ. Res., December 3, 1999; 85(12): 1192 - 1198.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
H. Ishibashi-Ueda, C. Yutani, M. Imakita, S. Kuribayashi, M. Takamiya, H. Uchida, K. Kichikawa, T. Suzuki, and H. Ishibashi-Ueda
Histologic Comparison of Coronary and Iliac Atherectomy Tissue from Cases of In-Stent Restenosis
Angiology, December 1, 1999; 50(12): 977 - 987.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Mezzetti, M. D. Guglielmi, S. D. Pierdomenico, F. Costantini, F. Cipollone, D. De Cesare, T. Bucciarelli, S. Ucchino, F. Chiarelli, F. Cuccurullo, et al.
Increased Systemic Oxidative Stress After Elective Endarterectomy : Relation to Vascular Healing and Remodeling
Arterioscler. Thromb. Vasc. Biol., November 1, 1999; 19(11): 2659 - 2665.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S.-I. Miyatake, H. Yukawa, H. Toda, N. Matsuoka, R. Takahashi, N. Hashimoto, and C. D. Kontos
Inhibition of Rat Vascular Smooth Muscle Cell Proliferation In Vitro and In Vivo by Recombinant Replication-Competent Herpes Simplex Virus • Editorial Comment
Stroke, November 1, 1999; 30 (11): 2431 - 2439.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Niebauer, S. P. Schwarzacher, M. Hayase, B. Wang, R. S. Kernoff, J. P. Cooke, and A. C. Yeung
Local L-Arginine Delivery After Balloon Angioplasty Reduces Monocyte Binding and Induces Apoptosis
Circulation, October 26, 1999; 100(17): 1830 - 1835.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. G. Macejak, H. Lin, S. Webb, J. Chase, K. Jensen, T. C. Jarvis, J. M. Leiden, and L. Couture
Adenovirus-Mediated Expression of a Ribozyme to c-myb mRNA Inhibits Smooth Muscle Cell Proliferation and Neointima Formation In Vivo
J. Virol., September 1, 1999; 73(9): 7745 - 7751.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. M. Bosmans, C. J. Vrints, M. M. Kockx, H. Bult, K. M. C. Cromheeke, and A. G. Herman
Continuous Perivascular L-Arginine Delivery Increases Total Vessel Area and Reduces Neointimal Thickening After Experimental Balloon Dilatation
Arterioscler. Thromb. Vasc. Biol., March 1, 1999; 19(3): 767 - 776.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Frimerman, P. J. Welch, X. Jin, N. Eigler, S. Yei, J. Forrester, H. Honda, R. Makkar, J. Barber, and F. Litvack
Chimeric DNA-RNA Hammerhead Ribozyme to Proliferating Cell Nuclear Antigen Reduces Stent-Induced Stenosis in a Porcine Coronary Model
Circulation, February 9, 1999; 99(5): 697 - 703.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
T. Todaka, C. Yokoyama, H. Yanamoto, N. Hashimoto, I. Nagata, T. Tsukahara, S. Hara, T. Hatae, R. Morishita, M. Aoki, et al.
Gene Transfer of Human Prostacyclin Synthase Prevents Neointimal Formation After Carotid Balloon Injury in Rats • Editorial Comment
Stroke, February 1, 1999; 30(2): 419 - 426.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. Ribichini, G. Steffenino, A. Dellavalle, A. Vado, V. Ferrero, T. Camilla, S. Giubergia, and E. Uslenghi
Plasma Lipoprotein(a) Is Not a Predictor for Restenosis After Elective High-Pressure Coronary Stenting
Circulation, September 22, 1998; 98(12): 1172 - 1177.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. J. Lansky, G. S. Mintz, J. J. Popma, A. D. Pichard, K. M. Kent, L. F. Satler, D. S. Baim, R. E. Kuntz, C. Simonton, R. M. Bersin, et al.
Remodeling after directional coronary atherectomy (with and without adjunct percutaneous transluminal coronary angioplasty): a serial angiographic and intravascular ultrasound analysis from the optimal atherectomy restenosis study
J. Am. Coll. Cardiol., August 1, 1998; 32(2): 329 - 337.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. Koyama and M. A. Reidy
Expression of Extracellular Matrix Proteins Accompanies Lesion Growth in a Model of Intimal Reinjury
Circ. Res., May 19, 1998; 82(9): 988 - 995.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
S. Nikol, S. Esin, S. Nekolla, T. Y. Huehns, J. Schirmer, M. Schwaiger, and B. Hofling
Use of Nuclear Magnetic Resonance Imaging Angiography to Follow-Up Arterial Remodeling in an Animal Model
Angiology, April 1, 1998; 49(4): 251 - 258.
[Abstract] [PDF]


Home page
CirculationHome page
A. Schomig, A. Kastrati, S. Elezi, H. Schuhlen, J. Dirschinger, F. Dannegger, M. Wilhelm, and K. Ulm
Bimodal Distribution of Angiographic Measures of Restenosis Six Months After Coronary Stent Placement
Circulation, December 2, 1997; 96(11): 3880 - 3887.
[Abstract] [Full Text]


Home page
CirculationHome page
R. Brandl, T. Richter, K. Haug, M. G. Wilhelm, P. C. Maurer, and W. Nathrath
Topographic Analysis of Proliferative Activity in Carotid Endarterectomy Specimens by Immunocytochemical Detection of the Cell Cycle–Related Antigen Ki-67
Circulation, November 18, 1997; 96(10): 3360 - 3368.
[Abstract] [Full Text]


Home page
CirculationHome page
H. Ueno, A. Haruno, N. Morisaki, M. Furuya, K. Kangawa, A. Takeshita, and Y. Saito
Local Expression of C-Type Natriuretic Peptide Markedly Suppresses Neointimal Formation in Rat Injured Arteries Through an Autocrine/Paracrine Loop
Circulation, October 7, 1997; 96(7): 2272 - 2279.
[Abstract] [Full Text]


Home page
CirculationHome page
M. Aikawa, Y. Sakomura, M. Ueda, K. Kimura, I. Manabe, S. Ishiwata, N. Komiyama, H. Yamaguchi, Y. Yazaki, and R. Nagai
Redifferentiation of Smooth Muscle Cells After Coronary Angioplasty Determined via Myosin Heavy Chain Expression
Circulation, July 1, 1997; 96(1): 82 - 90.
[Abstract] [Full Text]


Home page
NEJMHome page
D. R. Holmes
Preventing Coronary Restenosis and Complications
N. Engl. J. Med., June 12, 1997; 336(24): 1747 - 1749.
[Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Ueno, H. Yamamoto, S.-i. Ito, J.-J. Li, and A. Takeshita
Adenovirus-Mediated Transfer of a Dominant-Negative H-ras Suppresses Neointimal Formation in Balloon-Injured Arteries In Vivo
Arterioscler. Thromb. Vasc. Biol., May 1, 1997; 17(5): 898 - 904.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. M. Bosmans, M. M. Kockx, C. J. Vrints, H. Bult, G. R. Y. De Meyer, and A. G. Herman
Fibrin(ogen) and von Willebrand Factor Deposition Are Associated With Intimal Thickening After Balloon Angioplasty of the Rabbit Carotid Artery
Arterioscler. Thromb. Vasc. Biol., April 1, 1997; 17(4): 634 - 645.
[Abstract] [Full Text]


Home page
CirculationHome page
S. P. Schwarzacher, T. T. Lim, B. Wang, R. S. Kernoff, J. Niebauer, J. P. Cooke, and A. C. Yeung
Local Intramural Delivery of L-Arginine Enhances Nitric Oxide Generation and Inhibits Lesion Formation After Balloon Angioplasty
Circulation, April 1, 1997; 95(7): 1863 - 1869.
[Abstract] [Full Text]


Home page
CirculationHome page
W. D. Coats, P. Whittaker, D. T. Cheung, J. W. Currier, B. Han, and D. P. Faxon
Collagen Content Is Significantly Lower in Restenotic Versus Nonrestenotic Vessels After Balloon Angioplasty in the Atherosclerotic Rabbit Model
Circulation, March 4, 1997; 95(5): 1293 - 1300.
[Abstract] [Full Text]


Home page
StrokeHome page
F. Crawley, A. Clifton, H. Markus, and M. M. Brown
Delayed Improvement in Carotid Artery Diameter After Carotid Angioplasty
Stroke, March 1, 1997; 28(3): 574 - 579.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
T. C. Jarvis, F. E. Wincott, L. J. Alby, J. A. McSwiggen, L. Beigelman, J. Gustofson, A. DiRenzo, K. Levy, M. Arthur, J. Matulic-Adamic, et al.
Optimizing the Cell Efficacy of Synthetic Ribozymes. SITE SELECTION AND CHEMICAL MODIFICATIONS OF RIBOZYMES TARGETING THE PROTO-ONCOGENE c-myb
J. Biol. Chem., November 15, 1996; 271(46): 29107 - 29112.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Luo, T. Nishioka, N. L. Eigler, J. S. Forrester, M. C. Fishbein, H. Berglund, and R. J. Siegel
Coronary Artery Restenosis After Balloon Angioplasty in Humans Is Associated With Circumferential Coronary Constriction
Arterioscler. Thromb. Vasc. Biol., November 1, 1996; 16(11): 1393 - 1398.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Gerdes, V. Faber-Steinfeld, O. Yalkinoglu, and S. Wohlfeil
Comparison of the Effects of the Thrombin Inhibitor r-Hirudin in Four Animal Models of Neointima Formation After Arterial Injury
Arterioscler. Thromb. Vasc. Biol., October 1, 1996; 16(10): 1306 - 1311.
[Abstract] [Full Text]


Home page
CirculationHome page
L. A. Guzman, V. Labhasetwar, C. Song, Y. Jang, A. M. Lincoff, R. Levy, and E. J. Topol
Local Intraluminal Infusion of Biodegradable Polymeric Nanoparticles: A Novel Approach for Prolonged Drug Delivery After Balloon Angioplasty
Circulation, September 15, 1996; 94(6): 1441 - 1448.
[Abstract] [Full Text]


Home page
CirculationHome page
G. S. Mintz, J. J. Popma, A. D. Pichard, K. M. Kent, L. F. Satler, S. Chiu Wong, M. K. Hong, J. A. Kovach, and M. B. Leon
Arterial Remodeling After Coronary Angioplasty : A Serial Intravascular Ultrasound Study
Circulation, July 1, 1996; 94(1): 35 - 43.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S.-i. Ozeki, A. Ohtsuru, S. Seto, S. Takeshita, H. Yano, T. Nakayama, M. Ito, T. Yokota, M. Nobuyoshi, G. V. Segre, et al.
Evidence That Implicates the Parathyroid Hormone–Related Peptide in Vascular Stenosis : Increased Gene Expression in the Intima of Injured Rat Carotid Arteries and Human Restenotic Coronary Lesions
Arterioscler. Thromb. Vasc. Biol., April 1, 1996; 16(4): 565 - 575.
[Abstract] [Full Text]


Home page
CirculationHome page
R. Riessen, T. N. Wight, C. Pastore, C. Henley, and J. M. Isner
Distribution of Hyaluronan During Extracellular Matrix Remodeling in Human Restenotic Arteries and Balloon-Injured Rat Carotid Arteries
Circulation, March 15, 1996; 93(6): 1141 - 1147.
[Abstract] [Full Text]


Home page
CirculationHome page
R. Waksman, K. A. Robinson, I. R. Crocker, C. Wang, M. B. Gravanis, G. D. Cipolla, R. A. Hillstead, and S. B. King III
Intracoronary Low-Dose ß-Irradiation Inhibits Neointima Formation After Coronary Artery Balloon Injury in the Swine Restenosis Model
Circulation, November 15, 1995; 92(10): 3025 - 3031.
[Abstract] [Full Text]


Home page
ANGIOLOGYHome page
R. Brandl, P. C. Maurer, B. Hofling, and G. Bauriedel
Migration Behavior of Human Smooth Muscle Cells Cultivated from Restenotic and Primary Lesions
Angiology, November 1, 1995; 46(11): 973 - 980.
[Abstract] [PDF]


Home page
Circ. Res.Home page
P. G. Steg, M. Ziol, O. Tahlil, C. Robert, P. Masson, D. Pruneau, P. Bruneval, and P. Belichard
Reduction of Intimal Hyperplasia by Naroparcil, a 4-Methylumbelliferyl ß-D-Xyloside Analogue, After Arterial Injury in the Hypercholesterolemic Rabbit
Circ. Res., November 1, 1995; 77(5): 919 - 926.
[Abstract] [Full Text]